Letermovir 480 mg Tablet in India Exploring the Benefits in CMV Prevention

91 8750275027 l.w
1 / 1
Embed
Share

Letermovir tablets offer significant benefits in CMV prevention, especially for transplant patients. Available as Letermovir 240 mg in India, it helps reduce infection risks and improve patient outcomes. The medication is supplied by Impomed Healthca


Uploaded on | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. (+91) 8750275027 contact@impomedhealthcare.com C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. Home Who We Are What We Do Diseases Treatment FAQs Contact Us LETERMOVIR Home | Cancer | Blood Cancer | LETERMOVIR LETERMOVIR Tablets Description Composition Dosage Indications Contact Us LETERMOVIR 240 MG TABLETS PREVYMIS (letermovir) contains letermovir, an inhibitor of the CMV DNA terminase complex, and is administered orally or by intravenous infusio. PREVYMIS is available as 240 mg and 480 mg tablets. PREVYMIS tablets contain either 240 mg or 480 mg of letermovir and the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone 25, and film-coated with a coating material containing the following inactive ingredients: hypromellose 2910, iron oxide red (only for 480 mg tablets), iron oxide yellow, lactose monohydrate, titanium dioxide, and triacetin, Carnauba wax is added as a polishing agent. C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. +91-9007090388 +91-8750275027 contact@impomedhealthcare.com rahman@impomedhealthcare.com mohan.singh@impomendhealthcare.com Quick Links Diseases Corporate O?ce Home Who We Are What We Do Treatment FAQs Contact Us Blog Cancer Neurology Endocrinology Miscellaneous C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. , +91-8750275027 +91-9007090388 Established in New Delhi, India in 2020, ImpoMed Healthcare has grown over the years from a new start up to one of the Most Preferred Company for Facilitation of the USFDA/European FDA Approved. contact@impomedhealthcare.com rahman@impomedhealthcare.com Imported Drugs-Only mohan.singh@impomendhealthcare.com Follow us on: Copyright 2024 ImpoMed

Related


More Related Content